Novel Nasal Products and Formulations

Benjamin S Bleier, MD, FACS, is an Associate Professor and the Claire and John Bertucci Chair in Otolaryngology at Harvard Medical School and Massachusetts Eye and Ear. Dr Bleier is the Director of Translational Research, Endoscopic Skull Base Surgery, and Co-Director of the Center for Thyroid Eye Disease and Orbital Surgery. Dr Bleier is an R01 funded surgeon-scientist with 10 patents and over 200 peer-reviewed articles, book chapters, and textbooks. He lectures internationally on endoscopic management of orbit and skull base tumors as well as intranasal drug delivery to the brain. His work has been featured in TIME Magazine, CNN, Forbes, Wired, Popular Science, Boston Globe, Boston Magazine, and Harvard Medicine Magazine.

Dr Samantha (Sammy) Sarett is a Senior Director in the Genetic Medicine department at Eli Lilly. In her graduate research at Vanderbilt University, she designed effective and varied strategies for delivery of nucleic acid drugs. She built upon this foundation in postdoctoral work at AbbVie formulating diverse nanoparticle carriers before joining biotech Exicure. Since then, Dr Sarett has concentrated on design and evaluation of approaches to achieve extrahepatic delivery of nucleic acids. In her current research at Eli Lilly, she focuses on driving innovative and meaningful advances in this challenging and high-impact delivery space.